174 related articles for article (PubMed ID: 8675647)
21. Amplified Muc1-specific gene expression in colon cancer cells utilizing a binary system in adenoviral vectors.
Block A; Milasinovic D; Mueller J; Schaefer P; Schaefer H; Greten H
Anticancer Res; 2002; 22(6A):3285-92. PubMed ID: 12530077
[TBL] [Abstract][Full Text] [Related]
22. A new targeting approach for breast cancer gene therapy using the human fatty acid synthase promoter.
Yan C; Wen-Chao L; Hong-Yan Q; Rui Z; Wei-Lin J; Hua H
Acta Oncol; 2007; 46(6):773-81. PubMed ID: 17653900
[TBL] [Abstract][Full Text] [Related]
23. Targeted expression of toxic genes directed by pituitary hormone promoters: a potential strategy for adenovirus-mediated gene therapy of pituitary tumors.
Lee EJ; Anderson LM; Thimmapaya B; Jameson JL
J Clin Endocrinol Metab; 1999 Feb; 84(2):786-94. PubMed ID: 10022454
[TBL] [Abstract][Full Text] [Related]
24. Adenovirus-mediated tissue-targeted expression of the HSVtk gene for the treatment of breast cancer.
Anderson LM; Swaminathan S; Zackon I; Tajuddin AK; Thimmapaya B; Weitzman SA
Gene Ther; 1999 May; 6(5):854-64. PubMed ID: 10505111
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
Yang L; Hwang R; Chiang Y; Gordon EM; Anderson WF; Parekh D
Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543
[TBL] [Abstract][Full Text] [Related]
26. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
Wildner O; Morris JC
Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
[TBL] [Abstract][Full Text] [Related]
27. The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer.
Chang JY; Xia W; Shao R; Sorgi F; Hortobagyi GN; Huang L; Hung MC
Oncogene; 1997 Feb; 14(5):561-8. PubMed ID: 9053854
[TBL] [Abstract][Full Text] [Related]
28. Adenovirus-mediated gene therapy in an experimental model of breast cancer metastatic to the brain.
Colak A; Goodman JC; Chen SH; Woo SL; Grossman RG; Shine HD
Hum Gene Ther; 1995 Oct; 6(10):1317-22. PubMed ID: 8590736
[TBL] [Abstract][Full Text] [Related]
29. Adenoviral-mediated suicide gene therapy for hepatic metastases of breast cancer.
Kwong YL; Chen SH; Kosai K; Finegold MJ; Woo SL
Cancer Gene Ther; 1996; 3(5):339-44. PubMed ID: 8894253
[TBL] [Abstract][Full Text] [Related]
30. [Construction and identification of recombinant vectors carrying herpes simplex virus thymidine kinase genes expressed in vascular endothelial cells].
Liu XP; Li BJ; Zhang C
Ai Zheng; 2006 Feb; 25(2):179-84. PubMed ID: 16480582
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the promoter of the MUC1 gene overexpressed in breast cancer.
Zaretsky JZ; Sarid R; Aylon Y; Mittelman LA; Wreschner DH; Keydar I
FEBS Lett; 1999 Nov; 461(3):189-95. PubMed ID: 10567695
[TBL] [Abstract][Full Text] [Related]
32. [HSV-TK gene therapy of lung adenocarcinoma xenografts using a hypoxia/radiation dual-sensitive promoter].
Wang WD; Chen ZT; Li DZ; Duan YZ; Wang ZX; Cao ZH
Ai Zheng; 2004 Jul; 23(7):788-93. PubMed ID: 15248913
[TBL] [Abstract][Full Text] [Related]
33. Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors.
Vincent AJ; Vogels R; Someren GV; Esandi MC; Noteboom JL; Avezaat CJ; Vecht C; Bekkum DW; Valerio D; Bout A; Hoogerbrugge PM
Hum Gene Ther; 1996 Jan; 7(2):197-205. PubMed ID: 8788170
[TBL] [Abstract][Full Text] [Related]
34. Selective killing of AFP-positive hepatocellular carcinoma cells by adeno-associated virus transfer of the herpes simplex virus thymidine kinase gene.
Su H; Chang JC; Xu SM; Kan YW
Hum Gene Ther; 1996 Mar; 7(4):463-70. PubMed ID: 8800740
[TBL] [Abstract][Full Text] [Related]
35. Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models.
Eastham JA; Chen SH; Sehgal I; Yang G; Timme TL; Hall SJ; Woo SL; Thompson TC
Hum Gene Ther; 1996 Mar; 7(4):515-23. PubMed ID: 8800746
[TBL] [Abstract][Full Text] [Related]
36. Herpes vector-mediated delivery of marker genes to disseminated central nervous system tumors.
Kramm CM; Rainov NG; Sena-Esteves M; Chase M; Pechan PA; Chiocca EA; Breakefield XO
Hum Gene Ther; 1996 Feb; 7(3):291-300. PubMed ID: 8835217
[TBL] [Abstract][Full Text] [Related]
37. Eradication of breast cancer xenografts by hyperthermic suicide gene therapy under the control of the heat shock protein promoter.
Braiden V; Ohtsuru A; Kawashita Y; Miki F; Sawada T; Ito M; Cao Y; Kaneda Y; Koji T; Yamashita S
Hum Gene Ther; 2000 Dec; 11(18):2453-63. PubMed ID: 11119417
[TBL] [Abstract][Full Text] [Related]
38. Therapy of colon cancer with oncolytic adenovirus is enhanced by the addition of herpes simplex virus-thymidine kinase.
Wildner O; Blaese RM; Morris JC
Cancer Res; 1999 Jan; 59(2):410-3. PubMed ID: 9927055
[TBL] [Abstract][Full Text] [Related]
39. Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer.
Wills KN; Maneval DC; Menzel P; Harris MP; Sutjipto S; Vaillancourt MT; Huang WM; Johnson DE; Anderson SC; Wen SF
Hum Gene Ther; 1994 Sep; 5(9):1079-88. PubMed ID: 7833367
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of glioma cells in vitro and in vivo using a recombinant adenoviral vector containing an astrocyte-specific promoter.
Vandier D; Rixe O; Besnard F; Kim M; Rikiyama T; Goldsmith M; Brenner M; Gouyette A; Cowan KH
Cancer Gene Ther; 2000 Aug; 7(8):1120-6. PubMed ID: 10975672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
